Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Cardiol Therapeutics ( (TSE:CRDL) ) has shared an announcement.
Cardiol Therapeutics Inc. released its condensed interim consolidated financial statements for the three months ended March 31, 2025, revealing a net loss of $8.29 million, an improvement from the $9.18 million loss in the same period of 2024. The company’s cash and cash equivalents decreased to $23.29 million from $30.58 million at the end of 2024, reflecting ongoing investments in research and development. This financial update highlights the company’s continued focus on advancing its pipeline, despite financial challenges, and underscores its commitment to addressing unmet needs in cardiovascular health.
The most recent analyst rating on (TSE:CRDL) stock is a Buy with a C$9.00 price target. To see the full list of analyst forecasts on Cardiol Therapeutics stock, see the TSE:CRDL Stock Forecast page.
Spark’s Take on TSE:CRDL Stock
According to Spark, TipRanks’ AI Analyst, TSE:CRDL is a Underperform.
Cardiol Therapeutics faces substantial financial challenges, primarily driven by ongoing losses and negative cash flow. The stock’s technical indicators suggest mixed momentum, and its valuation is constrained by a negative P/E ratio. However, promising clinical developments and strategic advancements in heart disease treatments provide some positive outlook, though these are not sufficient to offset the financial and technical concerns.
To see Spark’s full report on TSE:CRDL stock, click here.
More about Cardiol Therapeutics
Cardiol Therapeutics Inc. operates in the biopharmaceutical industry, focusing on the development of anti-inflammatory therapies for the treatment of cardiovascular diseases. The company is primarily engaged in research and development activities, aiming to address significant unmet medical needs in the market.
Average Trading Volume: 87,056
Technical Sentiment Signal: Sell
Current Market Cap: C$131.4M
For detailed information about CRDL stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue